Items where authors include "Palmer, Stephen John"

Article

Duarte, Ana Isabel orcid.org/0000-0002-0528-4773, Corbett, Mark Stephen orcid.org/0000-0002-5937-1493, Melton, Hollie Anne orcid.org/0000-0003-3837-510X et al. (4 more authors) (2022) EarlyCDT Lung blood test for risk classification of solid pulmonary nodules : systematic review and economic evaluation. Health Technology Asssessment. IJFM4802. ISSN 2046-4924

Murphy, Peter James, Glynn, David orcid.org/0000-0002-0989-1984, Dias, Sofia orcid.org/0000-0002-2172-0221 et al. (4 more authors) (2022) Modelling approaches for histology-independent cancer drugs to inform NICE appraisals. Health technology assessment. ISSN 2046-4924

Nikolaidis, Georgios, Woods, Beth orcid.org/0000-0002-7669-9415, Palmer, Stephen John orcid.org/0000-0002-7268-2560 et al. (1 more author) (2021) Classifying information-sharing methods. BMC Medical Research Methodology. pp. 1-13. ISSN 1471-2288

Murphy, Peter James, Claxton, Lindsay orcid.org/0000-0002-1795-7568, Hodgson, Robert orcid.org/0000-0001-6962-2893 et al. (6 more authors) (2021) Exploring Heterogeneity in Histology-Independent Technologies and the Implications for Cost-Effectiveness. Medical Decision Making. pp. 1-14. ISSN 1552-681X

Corbett, Mark Stephen orcid.org/0000-0002-5937-1493, Duarte, Ana Isabel orcid.org/0000-0002-0528-4773, Llewellyn, Alexis orcid.org/0000-0003-4569-5136 et al. (7 more authors) (2020) Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation. Health Technology Asssessment. pp. 1-248. ISSN 2046-4924

Cox, Edward Miles, Wade, Rosalind Fay orcid.org/0000-0002-8666-8110, Peron, Mathilde Michelle Germaine et al. (4 more authors) (2019) The Clinical and Cost-Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia: an Evidence Review Group Evaluation of a NICE Single Technology Appraisal : Inotuzumab for the treatment of adult R/R B-cell ALL: an ERG perspective. PharmacoEconomics. pp. 1081-1091. ISSN 1179-2027

Saramago Goncalves, Pedro Rafael orcid.org/0000-0001-9063-8590, Yang, Huiqin orcid.org/0000-0003-3985-986X, Llewellyn, Alexis orcid.org/0000-0003-4569-5136 et al. (3 more authors) (2018) High-throughput, non-invasive prenatal testing for fetal RHD genotype to guide antenatal prophylaxis with anti-D immunoglobulin : a cost-effectiveness analysis. BJOG : an international journal of obstetrics and gynaecology. ISSN 1471-0528

Bojke, Laura orcid.org/0000-0001-7921-9109, Manca, Andrea orcid.org/0000-0001-8342-8421, Palmer, Stephen John orcid.org/0000-0002-7268-2560 et al. (3 more authors) (2017) How to appropriately extrapolate costs and utilities in cost-effectiveness analysis. Pharmacoeconomics. pp. 1-10. ISSN 1179-2027

Sideris, Eleftherios, Corbett, Mark Stephen orcid.org/0000-0002-5937-1493, Palmer, Stephen John orcid.org/0000-0002-7268-2560 et al. (2 more authors) (2016) The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis : A Critique of the Evidence. Pharmacoeconomics.. 1101–1110. ISSN 1179-2027

Neves De Faria, Rita Isabel orcid.org/0000-0003-3410-1435, Walker, Simon Mark orcid.org/0000-0002-5750-3691, Whyte, Sophie et al. (3 more authors) (2016) How to invest in getting cost-effective technologies into practice? : A framework for value of implementation analysis applied to novel oral anticoagulants. Medical Decision Making. ISSN 1552-681X

Walker, Simon Mark orcid.org/0000-0002-5750-3691, Asaria, Miqdad orcid.org/0000-0002-3538-4417, Manca, Andrea orcid.org/0000-0001-8342-8421 et al. (8 more authors) (2016) Long term health care use and costs in patients with stable coronary artery disease : a population based cohort using linked electronic health records (CALIBER). European Heart Journal — Quality of Care & Clinical Outcomes. p. 125. ISSN 2058-1742

Asaria, Miqdad orcid.org/0000-0002-3538-4417, Walker, Simon Mark orcid.org/0000-0002-5750-3691, Palmer, Stephen John orcid.org/0000-0002-7268-2560 et al. (8 more authors) (2016) Using electronic health records to predict costs and outcomes in stable coronary artery disease. Heart. ISSN 1468-201X

Monograph

Walker, Simon Mark orcid.org/0000-0002-5750-3691, Sculpher, Mark orcid.org/0000-0003-3746-9913, Claxton, Karl Philip orcid.org/0000-0003-2002-4694 et al. (1 more author) (2012) Coverage with evidence development, only in research, risk sharing or patient access scheme? : A framework for coverage decisions. Report. CHE Research Paper, 77 . Centre for Health Economics, University of York , York UK.

Claxton, Karl Philip orcid.org/0000-0003-2002-4694, Palmer, Stephen John orcid.org/0000-0002-7268-2560, Longworth, L. et al. (6 more authors) (2011) Uncertainty, evidence and irrecoverable costs: informing approval, pricing and research decisions for health technologies. Working Paper. CHE Research Paper . Centre for Health Economics, University of York , York, UK.

Conference or Workshop Item

Faria, Rita orcid.org/0000-0003-3410-1435, McKenna, Claire orcid.org/0000-0002-7759-4084 and Palmer, Stephen John orcid.org/0000-0002-7268-2560 Targeting subgroups to realise value : the cost-effectiveness of omalizumab in severe allergic asthma. In: UNSPECIFIED. (Unpublished)